Company / R&D per Share
RxSight, Inc. R&D per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.72
FY2025
5-year range
$0.72 / $0.92
FY2021-FY2025
Trend
-0.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $0.92 to $0.72 over the past 2 years.
Based on SEC 10-K filings.
0.72 in FY2025 with a 3-year CAGR of -7.1%.
Declined from $0.92 to $0.72 over the past 2 years.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -7.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, r&d per share decreased 0.0% year-over-year.
- Peak r&d per share was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.59 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.72 | -0.0% |
| FY2024 | $0.72 | -21.8% |
| FY2023 | $0.92 | +2.7% |
| FY2022 | $0.90 | +11.7% |
| FY2021 | $0.80 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026